{"id":23120,"date":"2023-07-28T10:26:30","date_gmt":"2023-07-28T17:26:30","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23120"},"modified":"2024-01-30T10:21:52","modified_gmt":"2024-01-30T10:21:52","slug":"ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/","title":{"rendered":"IgIV y neuropat\u00eda motora multifocal (NMM): una gu\u00eda completa para el tratamiento"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Si a usted o a un ser querido le han diagnosticado <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-multifocal-motor-neuropathy-mmn\/\">neuropat\u00eda motora multifocal (MMN)<\/a>Es muy probable que su proveedor de atenci\u00f3n m\u00e9dica le recomiende una opci\u00f3n de tratamiento llamada <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">terapia con inmunoglobulina intravenosa (IVIG)<\/a>La neuropat\u00eda motora multifocal, o NMM, es un trastorno neurol\u00f3gico poco com\u00fan y de progresi\u00f3n lenta que afecta los nervios perif\u00e9ricos, espec\u00edficamente los nervios motores que controlan los m\u00fasculos. Debido al da\u00f1o en los nervios motores, puede experimentar debilidad muscular, especialmente en brazos y manos, y dificultad para moverse.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-e95face6b64670fc32b6de1895e53911\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">Aunque todav\u00eda no existe cura para la MMN, la terapia con IgIV se prefiere como opci\u00f3n de tratamiento de primera l\u00ednea debido a sus beneficios en la mejora de la funci\u00f3n motora en la mayor\u00eda de los pacientes con MMN.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Este art\u00edculo proporciona una gu\u00eda completa para comprender mejor qu\u00e9 es la MMN y c\u00f3mo funciona el tratamiento con IgIV.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#What_Is_Multifocal_Motor_Neuropathy_MMN\" >\u00bfQu\u00e9 es la neuropat\u00eda motora multifocal (NMM)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#IVIG_as_a_First-line_Treatment_for_MMN\" >IgIV como tratamiento de primera l\u00ednea para la MMN<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#How_IVIG_Treatment_Works\" >C\u00f3mo funciona el tratamiento con IgIV<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Standard_IVIG_Dosage_for_MMN_Condition\" >Dosis est\u00e1ndar de IgIV para la enfermedad de MMN<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#How_IVIG_Improves_MMN_Condition\" >C\u00f3mo la IgIV mejora la condici\u00f3n de la MMN<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Promoting_Muscle_Strength\" >Fomentando la fuerza muscular<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Slowing_Disease_Progression\" >Retrasar la progresi\u00f3n de la enfermedad<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Reducing_Relapse_Frequency\" >Reducci\u00f3n de la frecuencia de reca\u00eddas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Enhancing_Quality_of_Life\" >Mejorando la calidad de vida<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Potential_Side_Effects_and_Precautions\" >Posibles efectos secundarios y precauciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#The_Treatment_Process_and_What_to_Expect\" >El proceso de tratamiento y qu\u00e9 esperar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#Conclusion\" >Conclusi\u00f3n<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Multifocal_Motor_Neuropathy_MMN\"><\/span>\u00bfQu\u00e9 es la neuropat\u00eda motora multifocal (NMM)?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La neuropat\u00eda motora multifocal es un trastorno cr\u00f3nico, progresivo y recurrente que se caracteriza por debilidad muscular que suele afectar diferentes partes del cuerpo de forma asim\u00e9trica (desigual). Por ejemplo, puede experimentar m\u00e1s debilidad en brazos y manos que en piernas. Con el tiempo, se vuelve m\u00e1s dif\u00edcil realizar actividades como vestirse, agarrar objetos, escribir o realizar tareas que requieren motricidad fina.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Este trastorno neurol\u00f3gico es m\u00e1s frecuente en hombres que en mujeres y suele progresar lentamente. Los pacientes pueden notar sus primeros s\u00edntomas entre los 40 y los 50 a\u00f1os.&nbsp;&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Aunque la causa exacta de la MMN sigue sin estar clara, se cree que se debe a que el sistema inmunitario del cuerpo ataca por error a los nervios. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-autoimmune-diseases\/\">autoinmune<\/a> La respuesta da\u00f1a la cubierta protectora del nervio, conocida como vaina de mielina, lo que conduce a un deterioro de la funci\u00f3n nerviosa.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_as_a_First-line_Treatment_for_MMN\"><\/span>IgIV como tratamiento de primera l\u00ednea para la MMN<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La inmunoglobulina intravenosa (IVIG) se utiliza como tratamiento de primera l\u00ednea para muchos pacientes, con el fin de controlar los s\u00edntomas de la NMM y mejorar su calidad de vida. Con la terapia IVIG, se infunde en el torrente sangu\u00edneo del paciente una soluci\u00f3n que contiene anticuerpos concentrados de donantes sanos. Estos anticuerpos act\u00faan como sustituto del sistema inmunitario del paciente, ayudando a suprimir la respuesta autoinmune responsable del da\u00f1o nervioso en la NMM.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Se han realizado m\u00faltiples ensayos cl\u00ednicos aleatorizados <\/span><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0022510X17300709\"><span style=\"font-weight: 400;\">Se ha demostrado la eficacia del tratamiento con IgIV para la MMN<\/span><\/a><span style=\"font-weight: 400;\"> hasta ahora<\/span><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_IVIG_Treatment_Works\"><\/span>C\u00f3mo funciona el tratamiento con IgIV<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Un paciente con MMN recibe una <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/immunoglobulins-ig\/\">inmunoglobulina<\/a> (IgG) a trav\u00e9s de un tubo delgado (cat\u00e9ter) insertado en la vena durante el tratamiento con IgIV. La infusi\u00f3n intravenosa suele durar varias horas y puede realizarse de forma ambulatoria o en casa, seg\u00fan la condici\u00f3n y las preferencias del paciente.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los anticuerpos presentes en la soluci\u00f3n de IgIV act\u00faan como se\u00f1uelos, desviando la respuesta autoinmune de los nervios. Esto ayuda a reducir la inflamaci\u00f3n y a prevenir mayores da\u00f1os a las vainas de mielina. Como resultado, el paciente experimenta una mejora en la fuerza muscular y la progresi\u00f3n de la enfermedad se ralentiza significativamente.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Standard_IVIG_Dosage_for_MMN_Condition\"><\/span><b>Dosis est\u00e1ndar de IgIV para la enfermedad de MMN<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis est\u00e1ndar de IgIV es de 0,4 g\/kg, administrada durante 5 d\u00edas consecutivos, con un total de 2 g\/kg. Sin embargo, algunos m\u00e9dicos prefieren una dosis de 1 g\/kg al d\u00eda durante 2 d\u00edas.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Dependiendo de la salud del paciente, la dosis de mantenimiento de seguimiento para las infusiones de IgIV podr\u00eda variar de 0,4 g\/kg una vez a la semana a 2 g\/kg cada 8 semanas.\u00a0<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-af7cb787e7711a8a42d4c52aeaa40865\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAsistencia financiera para la IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Consulte a un especialista en IgIV<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_IVIG_Improves_MMN_Condition\"><\/span>C\u00f3mo la IgIV mejora la condici\u00f3n de la MMN<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2.jpg\" alt=\"Smiling patient receiving IVIG infusion for multifocal motor neuropathy\" class=\"wp-image-23122\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-2-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">El tratamiento con IgIV es eficaz para mejorar la condici\u00f3n de la MMN de varias maneras:&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Promoting_Muscle_Strength\"><\/span><b>Fomentando la fuerza muscular<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Uno de los principales objetivos de la IgIV en la MMN es mejorar la fuerza muscular, especialmente en manos y brazos. A medida que se modula la respuesta inmunitaria y disminuye la inflamaci\u00f3n, los m\u00fasculos reciben mejor las se\u00f1ales nerviosas, lo que resulta en una mejor funci\u00f3n muscular.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Muchos pacientes tienen <\/span><a href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756285616629869\"><span style=\"font-weight: 400;\">reportado<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;aumento de la funci\u00f3n muscular y mejor fuerza de agarre despu\u00e9s de someterse a una terapia con IgIV. <\/span><span style=\"font-weight: 400;\">En uno <\/span><a href=\"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004429.pub3\/full\"><span style=\"font-weight: 400;\">estudiar<\/span><\/a><span style=\"font-weight: 400;\">, cinco pacientes que recibieron IgIV en una dosis de 0,4 g\/kg durante 5 d\u00edas mostraron una mejor fuerza en comparaci\u00f3n con los que recibieron un placebo despu\u00e9s de 28 d\u00edas.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">De manera similar, con base en cuatro ensayos cl\u00ednicos aleatorizados, se encontr\u00f3 que <\/span><a href=\"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004429.pub2\/full\"><span style=\"font-weight: 400;\">El 78% de los pacientes que recibieron terapia con IgIV experimentaron una mejora significativa en la fuerza muscular.<\/span><\/a><span style=\"font-weight: 400;\">En comparaci\u00f3n, solo el 4% de los pacientes que recibieron placebo mostr\u00f3 mejor\u00eda. Estos ensayos demuestran la eficacia de la IgIV. <\/span><a href=\"https:\/\/touchneurology.com\/neuromuscular-diseases\/journal-articles\/the-long-term-treatment-of-multifocal-motor-neuropathy-with-intravenous-immunoglobulin\/\"><span style=\"font-weight: 400;\">Tratamiento para mejorar la fuerza muscular y la discapacidad en pacientes con MMN<\/span><\/a><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Slowing_Disease_Progression\"><\/span><b>Retrasar la progresi\u00f3n de la enfermedad<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La NMM es una enfermedad cr\u00f3nica, y su progresi\u00f3n puede provocar mayor debilidad muscular y discapacidad con el tiempo. Se ha demostrado que el tratamiento con IgIV ralentiza la progresi\u00f3n de la NMM al prevenir un mayor da\u00f1o nervioso. Esta preservaci\u00f3n de la funci\u00f3n nerviosa ayuda a mantener la fuerza y la funci\u00f3n muscular, lo que permite a las personas con NMM disfrutar de una mejor calidad de vida.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reducing_Relapse_Frequency\"><\/span><b>Reducci\u00f3n de la frecuencia de reca\u00eddas<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La MMN se caracteriza por per\u00edodos de reca\u00eddas, donde los s\u00edntomas empeoran temporalmente. Se ha descubierto que el tratamiento con IgIV... <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6033107\/\"><span style=\"font-weight: 400;\">reducir la frecuencia y gravedad de estas reca\u00eddas<\/span><\/a><span style=\"font-weight: 400;\">La terapia con IgIV puede ayudar a minimizar el impacto de las reca\u00eddas y mantener una funci\u00f3n muscular m\u00e1s estable al proporcionar una respuesta inmune estable y constante.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Enhancing_Quality_of_Life\"><\/span><b>Mejorando la calidad de vida<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Con una mayor fuerza muscular y una reducci\u00f3n de los s\u00edntomas, los pacientes suelen experimentar una mejor calidad de vida. Esto les permite realizar sus actividades cotidianas con mayor facilidad.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La respuesta al tratamiento con IgIV puede variar de una persona a otra. Algunas personas pueden experimentar una mejor\u00eda significativa de los s\u00edntomas, mientras que otras pueden experimentar beneficios m\u00e1s moderados. En ocasiones, puede llevar varias semanas o incluso meses de tratamiento observar los efectos completos.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Potential_Side_Effects_and_Precautions\"><\/span>Posibles efectos secundarios y precauciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Si bien el tratamiento con IgIV es generalmente seguro, tambi\u00e9n tiene cierto potencial <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-long-term-side-effects\/\">efectos secundarios<\/a>Los pacientes con MMN pueden experimentar cefaleas leves, fatiga, fiebre y dolores musculares. Estos efectos secundarios suelen ser temporales y desaparecen a los pocos d\u00edas del tratamiento.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En casos raros, pueden presentarse efectos secundarios m\u00e1s graves, como reacciones al\u00e9rgicas, problemas renales o trastornos de la coagulaci\u00f3n sangu\u00ednea. Es fundamental consultar con su profesional de la salud sobre cualquier inquietud o posible factor de riesgo antes de iniciar el tratamiento con IgIV.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-f46aa0b5460d2897762ca4a6b60b5cad\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga su dosis de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInfusi\u00f3n en casa\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_Treatment_Process_and_What_to_Expect\"><\/span>El proceso de tratamiento y qu\u00e9 esperar<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Si el profesional de la salud determina que la IgIV es una opci\u00f3n de tratamiento adecuada para su MMN, colaborar\u00e1 con usted para desarrollar un plan de tratamiento individualizado. Este plan incluir\u00e1 detalles sobre la dosis, la frecuencia y la duraci\u00f3n de las infusiones de IgIV.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Durante el tratamiento, es posible que necesite acudir a una cl\u00ednica o recibir infusiones en casa. El personal m\u00e9dico monitorear\u00e1 sus constantes vitales y su respuesta al tratamiento para garantizar su eficacia y seguridad.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Es importante tener en cuenta que <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-to-expect-during-your-ivig-infusion-treatment\/\">Tratamiento con IgIV<\/a> El tratamiento de la MMN suele ser a largo plazo, a menudo durante meses o incluso a\u00f1os. Por lo tanto, es necesario realizar citas de seguimiento peri\u00f3dicas con su profesional de la salud para evaluar su progreso y realizar los ajustes necesarios al plan de tratamiento.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusi\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El tratamiento con IgIV se ha consolidado como una terapia altamente eficaz para el manejo de la neuropat\u00eda motora multifocal (NMM). Al modular la respuesta inmunitaria y reducir la inflamaci\u00f3n, la IgIV puede ayudar a mejorar la fuerza muscular, ralentizar la progresi\u00f3n de la enfermedad y mejorar la calidad de vida de los pacientes con NMM.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Por lo tanto, si usted o un ser querido padece de MMN, es fundamental consultar con un profesional de la salud con experiencia en el tratamiento de esta afecci\u00f3n. El m\u00e9dico adecuado le realizar\u00e1 una evaluaci\u00f3n integral y le guiar\u00e1 sobre las opciones de tratamiento, incluyendo la terapia con IgIV, as\u00ed como sus posibles beneficios y riesgos. Con el tratamiento y el apoyo adecuados, muchos pacientes con MMN pueden llevar una vida plena a pesar de los desaf\u00edos que presenta la afecci\u00f3n.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>If you or a loved one have been diagnosed with multifocal motor neuropathy (MMN), your healthcare provider is most likely to recommend a treatment option called intravenous immunoglobulin (IVIG) therapy. Multifocal motor neuropathy, or MMN, is a rare and slowly progressive neurological disorder that affects the peripheral nerves in your body, specifically motor nerves that control the muscles.<\/p>","protected":false},"author":13,"featured_media":23121,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[17],"class_list":["post-23120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-28T17:26:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-30T10:21:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment\",\"datePublished\":\"2023-07-28T17:26:30+00:00\",\"dateModified\":\"2024-01-30T10:21:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/\"},\"wordCount\":1204,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/immunoglobulin.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/\",\"name\":\"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/immunoglobulin.jpg\",\"datePublished\":\"2023-07-28T17:26:30+00:00\",\"dateModified\":\"2024-01-30T10:21:52+00:00\",\"description\":\"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/immunoglobulin.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/immunoglobulin.jpg\",\"width\":1280,\"height\":853,\"caption\":\"3d illustration of immunoglobulins\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care","description":"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care","og_description":"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-07-28T17:26:30+00:00","article_modified_time":"2024-01-30T10:21:52+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment","datePublished":"2023-07-28T17:26:30+00:00","dateModified":"2024-01-30T10:21:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/"},"wordCount":1204,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/","name":"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg","datePublished":"2023-07-28T17:26:30+00:00","dateModified":"2024-01-30T10:21:52+00:00","description":"In this guide to IVIG and Multifocal Motor Neuropathy (MMN), we go over the treatment and what to expect when undergoing IVIG for MMN.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg","width":1280,"height":853,"caption":"3d illustration of immunoglobulins"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-multifocal-motor-neuropathy-mmn-a-comprehensive-guide-to-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG and Multifocal Motor Neuropathy (MMN): A Comprehensive Guide to Treatment"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"If you or a loved one have been diagnosed with multifocal motor neuropathy (MMN), your healthcare provider is most likely to recommend a treatment option called intravenous immunoglobulin (IVIG) therapy. Multifocal motor neuropathy, or MMN, is a rare and slowly progressive neurological disorder that affects the peripheral nerves in your body, specifically motor nerves that&hellip;","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/immunoglobulin.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"If you or a loved one have been diagnosed with multifocal motor neuropathy (MMN), your healthcare provider is most likely to recommend a treatment option called intravenous immunoglobulin (IVIG) therapy. Multifocal motor neuropathy, or MMN, is a rare and slowly progressive neurological disorder that affects the peripheral nerves in your body, specifically motor nerves that&hellip;","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23120"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23120\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23121"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23120"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}